Lupin has announced plans to invest USD 250 million over the next five years to establish a new state-of-the-art manufacturing facility in Coral Springs, Florida. The facility will focus on producing over 25 essential respiratory medicines, including albuterol inhalers.

Spanning approximately 70,000 square feet across more than five acres, the new site is expected to create over 200 skilled, long-term jobs in Broward County by 2030.

This investment aims to strengthen domestic U.S. manufacturing capacity for critical respiratory therapies, enhance medicine security, and diversify Lupin’s global supply chain.

As part of the project, Lupin will also collaborate with local authorities and workforce development institutions, benefiting from available tax incentives and support from the state of Florida.